checkAd

     512  0 Kommentare Skystar Bio-Pharmaceutical Provides Update to Its Patent Portfolio - Seite 4

    Contacts:

    Skystar Bio-Pharmaceutical Company
    Scott Cramer
    Director - Corporate Development & U.S. Representative
    (407) 645-4433

    Grayling
     Investor Relations
    Christopher Chu
    (646) 284-9426
    Email Contact

    Lesen Sie auch


    Seite 4 von 4

    Verfasst von Marketwired
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Skystar Bio-Pharmaceutical Provides Update to Its Patent Portfolio - Seite 4 XI'AN, CHINA--(Marketwired - Apr 17, 2014) - Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, announced …